These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35886862)

  • 1. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
    Paolella G; Sposito S; Romanelli AM; Caputo I
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics.
    Papista C; Gerakopoulos V; Kourelis A; Sounidaki M; Kontana A; Berthelot L; Moura IC; Monteiro RC; Yiangou M
    Lab Invest; 2012 Apr; 92(4):625-35. PubMed ID: 22330344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and mechanistic analysis of Ca
    Sewa AS; Besser HA; Mathews II; Khosla C
    Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2407066121. PubMed ID: 38959038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
    Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
    J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
    Lindstad CB; du Pré MF; Stamnaes J; Sollid LM
    PLoS One; 2022; 17(4):e0266543. PubMed ID: 35385534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.
    Büchold C; Hils M; Gerlach U; Weber J; Pelzer C; Heil A; Aeschlimann D; Pasternack R
    Cells; 2022 May; 11(10):. PubMed ID: 35626704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
    Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of celiac disease in daily clinical practice.
    Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
    Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrates, inhibitors, and probes of mammalian transglutaminase 2.
    Zhuang R; Khosla C
    Anal Biochem; 2020 Feb; 591():113560. PubMed ID: 31874171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
    Paolella G; Nanayakkara M; Sposito S; Lepretti M; Auricchio S; Esposito C; Barone MV; Martucciello S; Caputo I
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
    Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
    J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.